Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
McKesson
Johnson and Johnson
Deloitte
UBS
Healthtrust
Merck
Julphar

Generated: April 23, 2018

DrugPatentWatch Database Preview

PARLODEL Drug Profile

« Back to Dashboard

When do Parlodel patents expire, and what generic alternatives are available?

Parlodel is a drug marketed by Us Pharms Holdings I and is included in one NDA.

The generic ingredient in PARLODEL is bromocriptine mesylate. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
Drug patent expirations by year for PARLODEL
Pharmacology for PARLODEL
Ingredient-typeErgolines
Drug ClassErgot Derivative
Medical Subject Heading (MeSH) Categories for PARLODEL
Synonyms for PARLODEL
(+)-Bromocriptine methanesulfonate
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-penta
(4R,7R)-10-BROMO-N-[(1S,2S,4R,7S)-2-HYDROXY-7-(2-METHYLPROPYL)-5,8-DIOXO-4-(PROPAN-2-YL)-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,9,12(16),13-
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
08Y
13177-EP2272832A1
13177-EP2275420A1
13177-EP2277876A1
13177-EP2280008A2
13177-EP2287165A2
13177-EP2287166A2
13177-EP2292614A1
13177-EP2292620A2
13177-EP2295412A1
13177-EP2295413A1
13177-EP2295439A1
13177-EP2298731A1
13177-EP2298738A1
13177-EP2298779A1
13177-EP2311808A1
13177-EP2311818A1
13177-EP2311829A1
13177-EP2311837A1
13177-EP2316470A2
13177-EP2316834A1
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-bromoergocriptine
2-Bromoergocryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergokryptine
22260-51-1 (mesylate (salt))
25614-03-3
3A64E3G5ZO
88085-EP2298415A1
88085-EP2298742A1
88085-EP2305648A1
AC-13601
AC1L1KXS
AC1Q2716
AKOS015961273
Alti-Bromocriptine
Apo-Bromocriptine
Bagren
BC206491
BDBM81993
BIDD:GT0464
Biomol-NT_000005
BPBio1_001131
BRD-K14496212-001-01-1
Bromergocryptine
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
bromocriptine
Bromocriptine (USAN/INN)
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
Bromocriptine [USAN:INN:BAN]
BROMOCRIPTINE MESYLATE
Bromocriptine methanesulfonate
Bromocriptine+ (GTP-)
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
CAS-25614-03-3
CB-154
CCG-204266
CCRIS 3244
CHEBI:3181
CHEMBL493
D03165
D06YFA
DB01200
DSSTox_CID_2687
DSSTox_GSID_22687
DSSTox_RID_76692
DTXSID1022687
EINECS 247-128-5
Ergocryptine, 2-bromo-
Ergocryptine, 2-bromo- (8CI)
Ergocryptine, 2-bromo-(8CI)
ergolactin
Ergoset
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
GTPL35
J-016067
Lopac0_000171
LS-64540
N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide
NCGC00024584-03
NCGC00024584-04
NCGC00024584-05
NCI60_001365
NSC169774
OZVBMTJYIDMWIL-AYFBDAFISA-N
Parlodel (TN)
Parlodel Snaptabs
PDSP2_001500
PL001219
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SCHEMBL25297
SPBio_002101
Tox21_110907
UNII-3A64E3G5ZO
ZINC53683151

US Patents and Regulatory Information for PARLODEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharms Holdings I PARLODEL bromocriptine mesylate CAPSULE;ORAL 017962-002 Mar 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I PARLODEL bromocriptine mesylate TABLET;ORAL 017962-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PARLODEL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I PARLODEL bromocriptine mesylate TABLET;ORAL 017962-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I PARLODEL bromocriptine mesylate TABLET;ORAL 017962-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I PARLODEL bromocriptine mesylate CAPSULE;ORAL 017962-002 Mar 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I PARLODEL bromocriptine mesylate CAPSULE;ORAL 017962-002 Mar 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Cantor Fitzgerald
Chubb
Healthtrust
Farmers Insurance
Baxter
Argus Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.